| Effect of memantine treatment on regional cortical metabolism in Alzheimer's disease. | |
| | |
MedLine Citation:
|
PMID: 20220580 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: Cortical systems involved in the response to medication treatment for Alzheimer's disease (AD) are poorly understood. Preclinical studies have demonstrated the effect of memantine on neuroreceptors and cell physiology, although the impact of treatment on cortical activity in vivo is not known. DESIGN: F-fluorodeoxyglucose positron emission tomography (PET) imaging and clinical assessment before and after open-label memantine treatment. PARTICIPANTS/SETTING: Seventeen outpatients with probable AD on stable cholinesterase inhibitor medication. INTERVENTION: Memantine up to 10 mg twice daily for 10 weeks. MEASUREMENTS: Voxel-based analyses of change in cortical metabolic activity; Mattis Dementia Rating Scale (DRS), and Neurobehavioral Rating Scale (NRS). RESULTS:: Mean age was 81 years; mean Mini-Mental State Examination score was 19.4. Compared with baseline, metabolic activity was significantly higher after 10 weeks memantine treatment in two cortical regions bilaterally: the inferior temporal gyrus (BA 20) and the angular gyrus/supramarginal gyrus (BA 39, 40). There was no significant relationship between change in DRS score and change in cortical metabolism, although change in NRS score was associated with the extent of metabolic change in the right parietal and temporal cortex. CONCLUSION: Metabolic activity in bilateral inferior parietal and temporal cortex increases during 10 weeks of memantine treatment in patients with AD. PET imaging can reveal functional effects of medications on neural activity and may help to define critical mechanisms involved in drug treatment. |
| | |
Authors:
|
David L Sultzer; Rebecca J Melrose; Dylan G Harwood; Olivia Campa; Mark A Mandelkern |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
Journal Detail:
|
Title: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry Volume: 18 ISSN: 1545-7214 ISO Abbreviation: Am J Geriatr Psychiatry Publication Date: 2010 Jul |
Date Detail:
|
Created Date: 2010-06-28 Completed Date: 2010-11-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9309609 Medline TA: Am J Geriatr Psychiatry Country: United States |
Other Details:
|
Languages: eng Pagination: 606-14 Citation Subset: IM |
Affiliation:
|
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA, CA, USA. dsultzer@ucla.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Aged, 80 and over Alzheimer Disease / drug therapy* Cerebral Cortex / drug effects*, metabolism*, radionuclide imaging Dopamine Agents / therapeutic use* Female Humans Male Memantine / therapeutic use* Neuropsychological Tests Parietal Lobe / drug effects, metabolism Positron-Emission Tomography Prospective Studies Temporal Lobe / drug effects, metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Dopamine Agents; 19982-08-2/Memantine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prevalence and correlates of poor self-rated health in the United States: the national elder mistrea...
Next Document: Prior depression history and deterioration of physical health in community-dwelling older adults--a ...